Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-07 Purchase | 2024-06-11 9:37 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 405,500 | $0.94 | $381,170 | 1,786,412 (Direct) | View |
| 2024-05-29 Purchase | 2024-05-31 5:29 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 10,434 | $0.91813 | $9,580 | 1,380,912 (Direct) | View |
| 2024-05-21 Purchase | 2024-05-23 5:29 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 22,889 | $0.90967 | $20,821 | 1,370,478 (Direct) | View |
| 2024-05-16 Purchase | 2024-05-20 5:40 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 74,565 | $0.91989 | $68,592 | 1,347,589 (Direct) | View |
| 2024-05-06 Purchase | 2024-05-08 4:10 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 320 | $0.89 | $285 | 1,273,024 (Direct) | View |
| 2024-05-01 Purchase | 2024-05-03 5:24 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 164,897 | $0.91985 | $151,680 | 1,272,723 (Direct) | View |
| 2024-04-19 Purchase | 2024-04-23 5:10 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 21,528 | $0.90215 | $19,421 | 1,107,807 (Direct) | View |
| 2024-04-09 Purchase | 2024-04-11 5:12 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 3,188 | $0.88 | $2,805 | 1,086,279 (Direct) | View |
| 2024-04-03 Purchase | 2024-04-05 5:18 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 17,378 | $0.91 | $15,814 | 1,083,091 (Direct) | View |
| 2024-03-27 Purchase | 2024-04-01 5:21 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 54,574 | $0.89994 | $49,113 | 2,037,426 (Direct) | View |
| 2024-03-19 Purchase | 2024-03-21 5:14 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 297 | $0.90966 | $270 | 1,011,139 (Direct) | View |
| 2024-03-11 Purchase | 2024-03-13 5:23 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 16,329 | $0.91559 | $14,951 | 1,010,842 (Direct) | View |
| 2024-02-26 Purchase | 2024-02-28 5:14 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 20,109 | $0.9 | $18,098 | 994,513 (Direct) | View |
| 2024-02-20 Purchase | 2024-02-22 5:26 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 77,404 | $0.88709 | $68,665 | 974,404 (Direct) | View |
| 2024-01-12 Purchase | 2024-01-17 4:50 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 19,996 | $0.98452 | $19,686 | 897,000 (Direct) | View |
| 2024-01-09 Purchase | 2024-01-11 4:53 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 51,502 | $0.98 | $50,472 | 877,004 (Direct) | View |
| 2024-01-03 Purchase | 2024-01-05 6:37 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 78,502 | $0.89696 | $70,413 | 825,502 (Direct) | View |
| 2023-12-20 Purchase | 2023-12-20 8:07 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital LLC 10% Owner | 47,000 | $0.84 | $39,480 | 747,000 (Direct) | View |
| 2023-12-08 Sale | 2023-12-11 4:08 pm | Fresh Tracks Therapeutics Inc. | FRTX | Fox-Collis Aaron VP of Finance & CAO | 74 | $0.91 | $67 | 0 (Direct) | View |
| 2023-12-04 Purchase | 2023-12-06 9:45 pm | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital Fund LP Exploration Capital LLC Exploration Capital General Partner LLC 10% Owner | 30,000 | $0.87872 | $26,362 | 700,000 (Direct) | View |
| 2023-12-04 Sale | 2023-12-04 4:59 pm | Fresh Tracks Therapeutics Inc. | FRTX | Fox-Colis Aaron VP of Finance & CAO | 36 | $0.8501 | $31 | 74 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-28 Disposition | 2024-01-09 4:11 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Fox-Collis Aaron VP of Finance & CAO | 8,000 | $0.91 | 0 (Direct) | View |
| 2023-12-28 Disposition | 2024-01-09 4:10 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Marchio Albert N II CEO and CFO | 1,250 | $0.91 | 0 (Direct) | View |
| 2023-09-01 Exercise | 2023-12-11 4:09 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Chadha Deepak Former Chief R&D Officer & COO | 35,000 | $0 | 22,314 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-12-11 4:09 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Chadha Deepak Former Chief R&D Officer & COO | 14,978 | $0.621 | 22,314 (Direct) | View |
Ownership | 2023-12-06 9:43 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Exploration Capital Fund LP Exploration Capital LLC Exploration Capital General Partner LLC 10% Owner | 0 | $0 | 670,000 (Direct) | View |
Ownership | 2023-12-01 4:15 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Fox-Colis Aaron VP of Finance & CAO | 0 | $0 | 11,501 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-04 9:41 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Sklawer Andrew D President and CEO | 20,833 | $0.9798 | 39,269 (Direct) | View |
| 2023-10-02 Exercise | 2023-10-04 9:41 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Sklawer Andrew D President and CEO | 55,000 | $0 | 39,269 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-04 9:40 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | McAvoy David R. Gen Counsel, CCO, & Secretary | 7,358 | $0.9798 | 16,371 (Direct) | View |
| 2023-10-02 Exercise | 2023-10-04 9:40 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | McAvoy David R. Gen Counsel, CCO, & Secretary | 20,000 | $0 | 16,371 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-26 6:49 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | McAvoy David R. Gen Counsel, CCO, & Secretary | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-26 6:49 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Sklawer Andrew D President | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-26 6:48 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | MARCHIO ALBERT N II Chief Financial Officer | 1,250 | $0 | 1,250 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-26 6:48 pm | N/A N/A | Fresh Tracks Therapeutics Inc. | FRTX | Chadha Deepak Chief R&D Officer and COO | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-17 5:18 pm | 2023-05-17 2032-05-17 | Brickell Biotech Inc. | BBI | HARDY REGINALD L CHAIRMAN OF THE BOARD | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-17 5:16 pm | 2023-05-17 2032-05-17 | Brickell Biotech Inc. | BBI | SAMANT VIJAY B Director | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-17 5:15 pm | 2023-05-17 2032-05-17 | Brickell Biotech Inc. | BBI | LYONS GARY A Director | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-17 5:14 pm | 2023-05-17 2032-05-17 | Brickell Biotech Inc. | BBI | VERU DENNISON T Director | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 4:17 pm | 2023-05-05 2032-05-05 | Brickell Biotech Inc. | BBI | McAvoy David R. General Counsel and CCO | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 4:17 pm | 2023-05-05 2032-05-05 | Brickell Biotech Inc. | BBI | Breton Jose Chief Accounting Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 4:17 pm | 2023-05-05 2032-05-05 | Brickell Biotech Inc. | BBI | Chadha Deepak Chief Research & Dev. Officer | 325,000 | $0 | 325,000 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 4:16 pm | 2023-05-05 2032-05-05 | Brickell Biotech Inc. | BBI | MARCHIO ALBERT N II Chief Financial Officer | 30,000 | $0 | 30,000 (Direct) | View |